United Therapeutics Corporation
Martine A Rothblatt (Chairperson & CEO) sells UTHR shares
AI-generated summary
Chairperson & CEO, Director Martine A Rothblatt exercised 9,500 options for 9,500 shares at an average price of $117.76 valued at $1,118,720 and sold 9,500 shares at an average price of $560.07 valued at $5,320,680.75. After the transactions, the insider indirectly held 324,443 shares by Trust. The transactions were made under a Rule 10b5-1 trading plan adopted on November 7, 2025.
Key facts
- Insider
- Martine A Rothblatt · Chairperson & CEO, Director
Rule 10b5-1 plan · adopted Nov 7, 2025
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Oct 21, 2026 | M · exercise or conversion of a derivativeFootnotes F1, F2 | +9,500 | $117.76 | $1,118,720.00 | 333,943 | Indirect (by Trust) |
| Oct 21, 2026 | S · open-market saleFootnotes F1, F3, F2 | −46 | $552.52 | $25,416.11 | 333,897 | Indirect (by Trust) |
| Oct 21, 2026 | S · open-market saleFootnotes F1, F4, F2 | −194 | $553.78 | $107,433.79 | 333,703 | Indirect (by Trust) |
| Oct 21, 2026 | S · open-market saleFootnotes F1, F5, F2 | −550 | $555.19 | $305,357.03 | 333,153 | Indirect (by Trust) |
| Oct 21, 2026 | S · open-market saleFootnotes F1, F6, F2 | −567 | $556.41 | $315,486.11 | 332,586 | Indirect (by Trust) |
| Oct 21, 2026 | S · open-market saleFootnotes F1, F7, F2 | −1,702 | $557.25 | $948,431.67 | 330,884 | Indirect (by Trust) |
| Oct 21, 2026 | S · open-market saleFootnotes F1, F8, F2 | −1,137 | $558.32 | $634,808.02 | 329,747 | Indirect (by Trust) |
| Oct 21, 2026 | S · open-market saleFootnotes F1, F9, F2 | −743 | $559.25 | $415,521.41 | 329,004 | Indirect (by Trust) |
| Oct 21, 2026 | S · open-market saleFootnotes F1, F10, F2 | −820 | $560.50 | $459,606.23 | 328,184 | Indirect (by Trust) |
| Oct 21, 2026 | S · open-market saleFootnotes F1, F11, F2 | −200 | $561.44 | $112,288.58 | 327,984 | Indirect (by Trust) |
| Oct 21, 2026 | S · open-market saleFootnotes F1, F12, F2 | −960 | $562.54 | $540,038.69 | 327,024 | Indirect (by Trust) |
| Oct 21, 2026 | S · open-market saleFootnotes F1, F13, F2 | −1,253 | $563.43 | $705,971.78 | 325,771 | Indirect (by Trust) |
| Oct 21, 2026 | S · open-market saleFootnotes F1, F14, F2 | −768 | $564.63 | $433,636.53 | 325,003 | Indirect (by Trust) |
| Oct 21, 2026 | S · open-market saleFootnotes F1, F15, F2 | −480 | $565.36 | $271,370.40 | 324,523 | Indirect (by Trust) |
| Oct 21, 2026 | S · open-market saleFootnotes F1, F2 | −80 | $566.43 | $45,314.40 | 324,443 | Indirect (by Trust) |
| Oct 21, 2026 | M · exercise or conversion of a derivativeStock OptionFootnotes F1, F19, F20 | −9,500 | $0.00 | $0.00 | 185,910 | Indirect (by Trust) |
Footnotes
- F1 This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026.
- F10 This transaction was executed in multiple trades at prices ranging from $559.96 to $560.90. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F11 This transaction was executed in multiple trades at prices ranging from $560.96 to $561.75. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F12 This transaction was executed in multiple trades at prices ranging from $562.00 to $562.99. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F13 This transaction was executed in multiple trades at prices ranging from $563.06 to $564.05. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F14 This transaction was executed in multiple trades at prices ranging from $564.08 to $565.07. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F15 This transaction was executed in multiple trades at prices ranging from $565.11 to $565.50. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F16 Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- F17 Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- F18 Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- F19 These stock options vested in equal one-third installments on March 15, 2021, 2022 and 2023.
- F2 Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- F20 Stock options held in a family trust as to which the Reporting Person shares investment power and the Reporting Person and immediate family members are beneficiaries.
- F3 This transaction was executed in multiple trades at prices ranging from $552.05 to $552.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4 This transaction was executed in multiple trades at prices ranging from $553.37 to $554.07. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5 This transaction was executed in multiple trades at prices ranging from $554.77 to $555.75. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6 This transaction was executed in multiple trades at prices ranging from $555.81 to $556.76. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F7 This transaction was executed in multiple trades at prices ranging from $556.81 to $557.76. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F8 This transaction was executed in multiple trades at prices ranging from $557.86 to $558.78. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F9 This transaction was executed in multiple trades at prices ranging from $558.92 to $559.85. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
More UTHR filings
- 4
Filed Oct 30, 2026
- 4
Filed Oct 29, 2026
- 4
Filed Oct 28, 2026
- 4
Filed Oct 27, 2026
- 4
Filed Oct 26, 2026
- 4
Filed Oct 23, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.